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The value of studying inherited metabolic abnormalities in cell lines devel- 
oped from the tissues of affected patients has been emphasized by BOtik and 
Kostman  (1956),  and  more  recently by  Kalckar  (1959a)  and  Luria  (1959), 
among  others.  Such  cell lines  may eventually prove useful for the  study of 
genetic changes  such  as  back  mutation,  recombination,  and  transformation. 
In addition, they should occasionally yield fresh information about the nature 
of the disease itself. 
One consideration, however, sharply limits the usefulness of cell culture  in 
the  study  of  genetically  determined  metabolic  abnormalities.  Cells  which 
propagate for long periods in culture usually retain few, if any, of the special- 
ized features of their tissue of origin (see Levintow and Eagle,  1960).  Thus, a 
"liver" or "muscle" culture is not generally a  collection of cells which can be 
shown to resemble liver or muscle. They are merely the cells which grew out 
when the specialized tissue was cultured. 
The  reason  that  cultured  cells do  not  in  general  resemble their  tissue  of 
origin is unknown. It does seem clear, however, that if one wishes at present to 
study a genetic disease among actively growing cells, the disease must fulfill at 
least one requirement: the abnormality should be demonstrable in most, if not 
all, of the tissues of the body. That is, the disease must not be one where the 
function deranged is peculiar to some single tissue, for that function may well 
"disappear" in cultures of cells from normal as well as affected donors. 
The  disease  galactosemia  appears  to  fulfill the requirement.  The  enzyme, 
galactose-l-phosphate uridyl transferase has been found in all normal tissues 
where  it  has  been  looked for.  In  the  corresponding tissues  of  galactosemic 
patients,  activity of  the  enzyme cannot be  demonstrated  (Kalckar,  1959a). 
The  disease  is  due  to  a  recessive  gene  with  heterozygotes having  enzyme 
activities about one-half normal  (Kirkman and Bynum,  1959). 
* Some of these investigations have been summaxized in a  preliminary note  published 
elsewhere (Krooth and Weinberg, 1960). 
1155 1156  GALACTOSEMIC CELLS  IN  CULTURE 
In  the present  paper,  growth  and  metabolic  studies  are described  using  cell 
lines  developed  from  the  tissues  of  galactosemics,  non-galactosemics,  and  a 
presumed  heterozygote.  Enzymatic  studies  upon  these  same  cell  lines  will 
be reported  (Bias  et  al.,  1961). 
Materials 
Clinical Data.-- 
A summary on the patients used in these studies is given in Table I. It should be noted 
that the three patients with congenital anomalies have been karyotyped and found  euploid. 1 
The  presumably  heterozygous patient  was  the  mother  of patient  JDU.  Brief clinical  de- 
scriptions of the two galactosemic patients  are as follows: 
TABLE  I 
Clinical Data 
Patient (line)  Age of  Tissue  patient  Sex  biopsied  Diagnosis 
RCU 
BY 
BE 
JDU 
JDU (R) 
MAD 
4~  mos. 
28 yrs. 
21  " 
11  " 
11  " 
38  " 
SK  3  " 
WIM  2~  " 
SE  20  " 
MI  27  " 
Female 
Male 
Female 
cc 
~g 
cg 
Male 
Skin 
Marrow 
Skin 
Marrow 
Multiple malformations 
Gaiactosemia 
Primary amyloidosis 
Galactosemia~ 
"  f 
Galactosemia heterozygote (Mother of 
JDU) 
Multiple malformations 
Wilson's disease 
Psoriasis and psoriatic arthritis 
B Y: 28  Year Old Male:  Mter an uneventful delivery and neonatal period this patient  de- 
veloped milk intolerence, nausea, vomiting, and failed to gain weight. At 3 months of age he 
was hospitalized and found to have malnutrition, anemia, hepatosplenomegaly, aibuminuria, 
and a urinary reducing substance which was later identified as galactose. On the institution 
of  a  galactose-free diet  the  melituria and  albuminuria  cleared,  the patient  gained  weight 
rapidly, and became symptom-free. Except for the development of cataracts and mild mental 
retardation  he has  remained  essentially well,  though  a  restriction  of galactose  was  never 
totally enforced.  The patient has a negative family history for galactosemia, and no  history 
of parental consanguinity. 
The  diagnosis of  galactosemia has  been  confirmed  by  assays  for  galactose-l-phosphate 
uridyl transferase in red blood cells and liver (Anderson et  al.,  1957). 
JDU:  11  Year  Old  Female:  The patient was  born  into a  family (originally reported  by 
Goldbloom and  Brickman,  1946) with two older siblings,  both of whom were affected  with 
galactosemia. Galactose was omitted from her diet from birth, although it is uncertain  how 
strictly this regimen was enforced. While the patient has never had the clinical symptoms or 
1 Karyotyping was carried out in collaboration with Dr. Hin Tjio, and  the technique and 
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signs  of gaiactosemia,  she has  an  abnormal  galactose tolerance test,  frequent  wines  with 
reducing substance, and a hemolysate of her red blood cells is unable to oxidize galactose-/- 
0  4 to C1~9~. 
Compo~tion  of Media and Solu~imm.-- 
A.  Growth medium: 
By ~olume 
Pooled whole human sera  2  12 per cent 
NCTC109 (McQuilkin et al., 1957)  5  "  " 
Minimum essential medium (Eagle, 1959)  83  "  " 
Supplement  Final concentration 
Pyruvate  I  milllmolar 
"Non-essential" 
Amino acids  each at  1 milllmolar 
(Alanine, proline, serine, glycine, glutamic acid, asparaglne, and aspartic acid) 
B.  Experimental  Media: 
By volume 
Dialyzed pooled human sera  12 per cent 
Hexose-free minimum essential medium  88  "  " 
The supplements are identical with those used for the growth medium, except that hexose 
is added as a supplement. The kind and final concentration of added hexose will be described 
subsequently. Sodium pyruvate was kindly prepared for us by Dr. Leon Levintow (Levintow 
and Price, 1952, Montgomery and Webb, 1954). No commercial pyruvate was used. 
Trypsin Solutions. 
Trypsin  (1:300,  Nutritional  Biochemicais,  Cleveland)  was  dissolved  at  concentrations 
of 0.05  and  0.25  per  cent in  a  solution described by Puck eta/.  (1958),  and is 40 per cent 
medium ~  15  and 60 per cent saline G  in  their notation.  1 per cent of antibiotic solution 
(Puck et al.) was  added. 
Conditions of Dialysis.- 
Pooled whole human serum, free of hemoglobin, is dialyzed 1 liter at a time for 21 hour  s 
against running tap water and then 3  hours against lnmnlng distilled water, at about  5°C" 
The rate of flow is 425 ml./minute. The dialysis bag consists of cellulose casing (The Visking 
Corporation,  Chicago) with an inflated diameter of 30/32 inches.  The bag is mounted on a 
rocking table throughout  the whole of the dialysis. Following the dialysis, the serum is free 
of glucose when tested by the method discussed by Chang  (1960) using glucose oxidase on 
paper sticks (cliniztix,  Ames Co., Inc., Elkhart, Indiana). 
Source of Hexose.-- 
D-glucose  and/or v-gaiactose (both Nutritional Biochemicals) were added  to  the  experi- 
mental media. The galactose was first recxystallized from 70 per cent ethanol (after the method 
used  by  Kalckar  et  al.,  1959b)  to  remove contaminating  glucose.  Galactose-l-C  n  (specific 
activity 4.72  uc.  per rag.)  was  obtained  from the National  Bureau  of  Standards  and was 
chromatographically pure.  Glucose-l-C  x4  (specific  activity 6.74  uc.  per  rag.)  was  obtained 
from the same source. 
2 For cell lines developed from bone marrow, 40 per cent type A1 B  single donor  human 
serum is used; the other constituents of the growth medium are the same. 1158  GALACTOSE~[IC  CELLS  IN  CULTURE 
Methods 
Development of the Cell Line From the Biopsy: 
A  technique for developing permanent euploid cell lines from human biopsies was 
published  by  Puck,  Ciecura,  and  Robinson  in  1958.  Although  our  methods  differ 
somewhat from theirs, the principles are the same. 
A. Skin Biopsies.--The area biopsied in every case was the lateral surface of the shoulder, 
at about the level of the neck of the humerus. The skin was thoroughly scrubbed with phiso- 
hex, 8 using a  surgical brush, and then prepared first  with zephirin  3 and finally with 70 per 
cent ethanol. As much friction as possible was used in the preparation to  ensure  absolute 
sterility. 1 per cent procaine or xylocaine was infused intradermally and then subcutaneously, 
and a  disc of skin 4 mm. in diameter was cut with a skin punch. Care  was taken to include 
dermis, and subcutaneous fat was always visible when the disc was  lifted up and its  pedicle 
cut. 
The tissue was placed in a  dish, cut into 5 to 8 pieces with newly sharpened conjunctival 
scissors,  and the pieces then partially minced. 5 ml. of  0.25 per cent trypsin solution  were 
added, and the suspension of explants was transferred to a  25 ml. Erlenmeyer  flask. 5 to  10 
additional ml. of trypsin were added. The flask was stoppered and placed in a  water  bath 
shaker, adjusted to 37.5°C.  Following agitation for 25 minutes, the suspension  (now  consist- 
ing of explants and cells) was transferred to a centrifuge tube and spurt at 500  to 1500 R.p.~r. 
for  10 minutes. The supernataut trypsin was removed, and the explants and cells were re- 
suspended in 6 ml. of growth medium. The suspension was divided among 3 Petri  dishes  (2 
inches in diameter) and the dishes were incubated in 5 per cent CO2  (saturated  with water 
vapor) at 37.5°C.  At 48 to 72 hours, the medium was removed (care being taken to leave the 
explants in the dish) and 0.60 to 0.75 ml. of fresh medium was added to each dish. Thereafter, 
this volume of medium was used and was changed every 48 hours. Large quantities of medium 
(of the order of 4 ml.) appeared to prevent growth when working with these minute quan- 
tities of tissue. In 4 or 5 days, individual "fibroblasts" (fusiform, transparent cells)  could be 
seen attached  to  the glass,  mainly in the immediate vicinity of  the explants,  from which 
most of them appeared to migrate. Epithelial outgrowths occurred from a number of explants. 
The epithelial monolayers eventually disappeared,  and no epithelial cells were noted after 
trypsinization for the first subculture.  Fibroblastic and epithelial outgrowths are shown  in 
Fig. I. This finding is consistent with that reported by Puck eta/., 1957. 
15 to 25 days after the biopsy, from 10 to 20 per cent of the surface of 2 or 3 primary 
dishes was covered with one or more colonies of confluent cells; 1 dish was then  subcultured 
with 0.25 per cent trypsin solution, the explants being left in the original dish. After decanting 
the typsin suspension, the explants were reincubated with growth medium. 
B. Bone Marrow Propagation.--Sternal marrow  aspirates  were  obtained  by  the  usual 
technique. The aspirate was collected in 5 ml. of a  solution of 40 per cent N 15 (Puck et aL, 
1958)  and 60 per cent of their saline G  to which 1 per cent of their antibiotic solution  and 
several drops of  I00 mg./ml, aqueous heparin had been added.  The suspension was centri- 
fuged for 10 minutes at 500 to 1500 R.P.M. and the fat floating on top of the supernatant and 
the buffy coat were inoculated into a total of 3 to 6 small tissue culture flasks (Tls), each con- 
taining 3 ml. of marrow growth medium. Thereafter, except for the serum composition of the 
medium (see Materials) the cultures were handled like those developed from skin. It should 
be noted that vast numbers of recognizable marrow elements attached to glass (and may even 
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have proliferated) in the primary bottles, but these did not come over on subculture. Here, 
as with skin, experiments were performed with the "fibroblastic" cells which eventually pre- 
dominated. Marrow fat and the buffy coat appeared to yield these cells about equally. 
Subculturing; Propagation; Computation of M-Numbers: 
Cells were incubated with trypsin solution (in an air atmosphere) at 37.5°C. for 15 minutes 
to digest them off the glass. 0.25 per cent trypsin was  used  for the first  subculture and 0.05 
per cent trypsin for the subsequent ones. The trypsin suspension was centrifuged, the super- 
natant removed,  and the cells resuspended  in growth medium for reinoculation.  Following 
the first subculture, larger volumes of media were employed. At each feeding about 0.2  ml 
of media were used for every square centimeter of surface area available for cell growth in 
the containing vessel. 
Cells were at all times maintained as monolayers in Petri dishes and bottles, and after the 
first subculture were fed every 72  hours.  When the ceils  of  the layer became confluent,  a 
fraction of them was subcultured into a fresh vessel. The fraction varied from ½  to  ~f~0~y. A 
continuous record of the fraction by which each culture was split and the size of the surface 
it covered was kept.  From these records the M-number, the minimum number of times the 
cells had increased as of a given moment, could be computed. All "growth" of cells in the pri- 
mary dish, the one containing the explant, was assumed to be exfoliation, and growth was not 
counted until the first subculture. Almost certainly we thereby underestimated  cell  growth. 
After subculturing from the primary dish, the explants were fed until a  new monolayer 
was generated--the new cells apparently coming largely from a fringe of the previous mono- 
layer  adhering to  the explant.  When inadequate growth or other difficulties  were encoun- 
tered  with a cell line the line was started again with another wave of cells from the primary 
dish.  In computing M-numbers growth in the primary dish was still ignored. We have thus 
far found no differences between successive samples of cells obtained in this way.  However a 
discrepancy between the M-number and the age of the culture results from this practice. 
Experimental Techniques: 
Growth Experiments.--Mter  at least two subcultures, the cells derived from skin were used 
in growth experiments: a large flask (a Ts0 or a Blake bottle) of cells was subcultured into 20 
to  100 smaller flasks  (T16's). 24 hours later, after the cells had attached and  spread,  they 
were washed with Eagle's (1959)  minimum essential medium from which the hexose had been 
omitted. A random sample of 4 or 5 bottles was then taken to determine the initial cell pro- 
tein. The remaining bottles were divided into 5 groups, and each group  was  overlaid with 
experimental media containing a  different concentration of hexose. The  five  concentrations 
of hexose used were: 
100 mg. per cent glucose 
100 rag. per cent galactose 
5 mg. per cent glucose 
95 rag. per cent galactose  and  5  mg.  per  cent glucose  (mixed  hexose) 
Hexose--free 
Cells were not exposed to galactose prior to the experiments. Each kind of  medium was 
changed every 72 hours. Between 9 and 18 days after placing the ceils in experimental media, 
the cell protein was again determined.  Measurement of cell protein was by the  method of 
Oyama and Eagle (1956).  Cell protein is expressed in terms of the amount of bovine  serum 
albumen giving the same optical density with the reagents used.  (In the graphs  and  tables 
one unit of protein corresponds to I00 ttg. of bovine albumen. All values are based on the mean 
of  2  to  4  replicate bottles--usually 3). 1160  GA~LACTOSEMIC  C~,LLS  IN CD-L'I'U~J~ 
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TABLE  III 
Growth Experiments with Galaaosemic Cells (aa) 
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Line 
Duration, days... 
Initial protein... 
100 Gin ......... 
I00 Gal .......... 
95/5 ............. 
5 Gin ............ 
Hexose-free ...... 
"Age" doys ...... 
M-Nos  ........... 
i'D1  By6 
9  9 
1,  0.9 
5.  3.3 
2  1.5 
5  3.0 
5,  3.4 
I,  1.1 
55  104 
60  12 
JDU  7 
9 
0.7 
2.0 
1.1 
1.6 
2.0 
1.0 
69 
64O 
JDUT~ 
9 
0.6 
1.5 
0.9 
1.2 
1.7 
0.9 
71 
120 
B"  ~  JDU  7, 
18  15 
0  0.6 
3  2.2 
1  1.2 
2  1.7 
3  2.2 
1  1.0 
122  77 
80  120 
JDU  5 
180.  9 
8.5 
3.0 
8.7 
2.6 
77 
80 
JDUto 
27 
0.6 
4.9 
1.4 
3.5 
4.5 
1.5 
145 
1.1  X  104 
JDU, 
9 
0 
4 
I 
3 
3 
1 
147 
4.8× 
~*  JDUy* 
16 
6  0.6 
9  5.7 
8  1.8 
3  3.9 
8  4.8 
7  1.5 
154 
lOS  4.8  X  lOS 
See Table II for notstion. 
* Part  of a multiple point experiment. 
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TExT-FIG.  1 
Two  types d  growth experiment were performed:  in the  "2-point"  experiments  only the 
initial cell protein and  the cell protein at  the end of  the experiment was determined.  In  the 
"multiple point"  experiments,  cell proteins  were  determined  on  bottles removed  every  72 
hours.  In most of the two point experiments and all the multiple point experiments,  galacto- 
semic cells were  run  concurrently  with non-galactosemic cells,  the  two  kinds of  cells  being 
fed with the same media. 
Isotope Experlmenls.--Equal  aliquots of cells were incubated with glucose-l-C  14 or  galac- 
tose-l-C  l+,  and  the  activity of  the  C1402  produced  was  determined.  The  techniques  were 
those of Weinberg and Segal (1960). 1162  GALACTOSEMIC  CELLS  IN  CULTURE 
RESULTS 
Growth Experiments: 
A.  The ttomozygous Lines.- 
Relative  growth in glucose and galactose: Tables II and III contain the data 
from our two point experiments. Included also in the Tables are the data from 
the 9th and final day of those multiple point experiments in which the cells 
were grown in all 5 experimental media. Note that among the non-galactosemic 
cells (Table II) the growth in galactose is about equal to the growth in glucose. 
The galactosemic cells,  however, grow better in glucose. The growth in galac- 
tose is about equal to the growth in medium which is hexose-free. 
In Text-fig. 1, using the data from Tables II and III,  growth ascribable to 
glucose is plotted against growth ascribable to galactose for galactosemic  (aa) 
and non-galactosemic cells (AA).  The index I~lu is defined: 
Growth  (final cell protein) in medium containing  100 rag. per cent 
l,lu  ---  glucose minus growth in hexose-free medium 
Inoculum (initial cell protein) 
Is,1 is the corresponding function for galactose. 
The two types of cells appear to differ sharply. The aa line may not have a 
zero slope, perhaps due to the presence of minute quantities of glucose in the 
galactose; glucose is known to persist as a contaminant of galactose even after 
two crystallizations in 70 per cent ethanol  (Kalckar, 1960). 
In Tables II and III, note the marked variation from experiment to experi- 
ment in the absolute growth rate. Some of this variation is probably spurious. 
A few of the experiments (e.g., one JDU 5 and one JDU  1° in Table III) were 
deliberately allowed to run for a long period of time after the cells had built up 
to see if the galactosemic cells in galactose would ever tend to catch up with 
the ones in glucose. In addition, we have evidence that there is variation from 
experiment to experiment in the population density at which the cells plateau, 
a  phenomenon which is easily confused with a  slow  growth rate in two point 
experiments. Beyond this, however, there is  a  true variation in  the absolute 
parameter of growth from experiment to experiment. It is of interest that the 
differences in growth rate and in the density at which the cells plateau usually 
characterize the experiment rather than the line. Cells from an individual donor 
have not in most cases tended consistently to grow well or poorly. It is our im- 
pression that the variation we observe may be due chiefly to the character of 
the serum in the medium (Puck et al.,  1957), possibly involving immunological 
reactions between serum and cell, rather than to some intrinsic property of the 
cell. Superior and more uniform growth appears to result when pretested serum 
is employed in our hands as well as Puck's (1957).  However, adequate screen- 
ing has not always been possible. 
In  Text-fig. 2,  data from a  multiple point experiment are given.  Both the R. S, BOOTH  AND  A, N. WEINBERG 
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galactosemic and  non-galactosemic cells  grew  well  in  this  experiment.  Note 
that the galactose curve in the case of the non-galactosemic cells follows the 
glucose curve,  whereas  in  the  galactosemic cells  it  winds  about  the  hexose- 
free curve. 
In Fig. 2, photographs are shown of galactosemic and non-galactosemic cells 
growing in the two sugars. The photographs are of replicate bottles and  were 
taken at 9 days. 
Galactose sensitivity:  Growth in media containing 5 rag. per cent glucose was 
compared with  growth  in  media  containing  the  mixture  of  95  rag.  per  cent 
galactose and 5 rag. per cent glucose. We wished to see if galactose sensitivity 
of the sort observed in the Gal-I-P uridyl  4 transferase mutants of Escherichia 
coli  (Kurahashi  and  Wahba,  1957  and  1958,  Kalckar  et  al.,  1957)  occurred 
among human galactosemic cells. 
Our  multiple  point  experiments  when  pooled  yielded  14  observations  in 
which  mean growth  was  simultaneously recorded in  the  medium  containing 
the mixture of 95  mg.  per cent galactose  and  5  mg.  per cent glucose  (95/5 
medium) and the medium containing 5 rag. per cent glucose (0/5 media). The 
data  6 are as follows: 
Presumed  genotype 
AA 
Growth in 95/5 
greater  than 
growth in 0/5 
Growth in 0/5 
greater than 
growth in95/5 
3 
11 
Growth equal  !  Total 
i 
l 
_1 
14 
14 
It would appear from the data on the non-galactosemic cells that growth in 
the mixed media is, if anything, better than growth in 5 rag. per cent glucose 
alone. Among  the galactosemic cells,  however, growth in  the mixed medium 
is usually poorer than growth in glucose alone. Perhaps the superior growth of 
the AA  cells in 95/5 is due to the greater concentration of hexose which seems 
important at high population densities or perhaps to some synergistic combina- 
tion of the two hexoses--we are not sure which. In either case one would not 
expect better growth in 95/5 among the aa cells since they appear to be unable 
to  utilize  galactose.  However, inability  to  utilize galactose  does  not  explain 
the fact that the aa cells do less well in the medium containing galactose. There- 
fore, these data  at  least  suggest  that  the growth of  galactosemic cells is  in- 
hibited by galactose. 
The significance of these data can be tested by chi square, letting the assump- 
tion of equal growth in 95/5 and 0/5 generate the expected numbers. On this 
4 Galactose-l-phosphate  uridyl transferase. 
Growth was considered greater in one medium than in another ff the  means of 2 to  4 
replicates in the two differed  by an amount of protein equivalent to at least 10/zg. of bovine 
albumen. R.  S.  KROOTI:I  AND  A.  N.  WEINBERG 
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assumption,  6 there should be as many cases where growth is better in 95/5 as 
cases where growth is poorer, that is, 6 and 6, rather than 1 and 11. Chi square 
(using Yates' correction) is 6.8  for one degree freedom, which is significant. 
In Text-fig. 3,  a  multiple point experiment is graphed.  The effect is small. 
Note that the action of galactose appears to delay growth for the first 72 hours 
or less. Thereafter,  the curves rise with equal slope. This type of an effect is 
similar to that reported by Kurahashi  and Wahba  (1957)  in certain of their 
experiments where transferase mutants of E. coli were grown in a  mixture of 
glucose  and  galactose.  Our  effect,  considering the  19:1  ratio of galactose to 
glucose we use, is much smaller than the one they noted. However, they also 
noted that the galactose sensitivity could be abolished by the addition to the 
medium of 500 mg. per cent whole yeast extract. It is possible that the dialyzed 
serum  in  our  experimental  media  is  partially  supplying  the  same  unknown 
principle. 
The two point experiments seem (to us) to be less suited for detecting a small 
difference in growth rate. The data are as follows: 
Growth in 95/5  Growth in 0/5 
Presumed genotype  greater than  greater than  Equal growth  Total 
growth in 0/5  growth in 95/5 
AA  8  3  1  12 
aa  0  5  0  5 
The data therefore resemble the findings in the multiple point experiments. 
However, the 5 observations do not differ significantly from the expected values 
of 2.5 in each class on the null hypothesis. If one takes all the data in Table III 
(which includes 4 entries from multiple point experiments), there are 9 observa- 
tions,  with  growth  in  0/5  being greater  than  growth  in  95/5  in  every case. 
Summing the terms of a binomial expansion, a  two-tailed probability of getting 
such data or a poorer fit on the null hypothesis is 1/256. The data on galactose 
sensitivity in Tables II and III are graphed in Text-fig. 4. 
If,  in Table III,  one compares growth in media containing 100 mg. per cent 
glucose with growth in 95/5,  we find better growth in the former case in 8 in- 
stances, and in the latter in 2, which is non-significant. Table III also reveals 
that  the  aa  cells  generally yield  slightly  less  protein  in  hexose-free medium 
than  in  medium containing  100  mg.  per  cent  galactose.  This  prima facie  is 
6 A  non-parametric test rather than an analysis of variance of the actual protein values is 
used. Occasionally,  3 or 4 replicate bottles in the same medium will contain one value markedly 
different from the  others. Sometimes the  reason is discernible (contamination, inadequate 
washing of the bottle before use, etc.). Other times it is not. In both cases the  extreme value 
is omitted. We are confident this practice gives us better estimates of the mean than would 
the inclusion of extreme observations. It deprives us, however, of the right to  estimate the 
variance among replicate bottles. R. S. KROOTH  AND  A. N. WEINBERG  1167 
inconsistent with a galactose sensitivity effect. We suspect that minute quanti- 
ties of glucose contaminating our galactose may make the comparison unfair. 
I0.0  • 
8.0  • 
6.0 
4.0 
2.0 
I  I 
• AA 
0  aa 
0  I  I  r 
0  2,0  4.0  6.0  8,0  I0.0 
z% 
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TABLE IV 
Gra~:tk Experirn~¢s with the Hdcrosygous  Line (Aa) 
Line 
Duration, days ........... 
Initial protein ............ 
100 Glu .................. 
100 Gal .................. 
95/5 .................... 
5 Glu .................... 
Hexose-free .............. 
"Age" (days) ............. 
M-Nos  ................... 
9 
0.7 
2.1 
1.5 
2.2 
1.2 
76 
128 
HADs 
18 
0.9 
3.4 
2.3 
3.2 
1.7 
93 
64 
13 
1.1 
4.0 
3.8 
4.0 
3.9 
1.8 
139 
36 
]~hI)1¢ 
35 
0.6 
3.1 
1.4 
2.4 
1.9 
1.4 
153 
512 
MAD0 
32 
0.9 
3.0 
3.0 
2.7 
1.6 
1.5 
155 
40 
28 
0.7 
2.6 
2.3 
2.5 
2.9 
1.4 
151 
108 
MADI' 
9 
1.1 
3.9 
3.9 
4.6 
1.6 
195 
2.3X  104 
See Table II for notation. 
Certainly the inclusion of pyruvate and the non-essential amino acids (includ- 
ing alanine) in the  medium renders the  cells exquisitely sensitive to  glucose 
(Chang and Geyer, 1957). 
The  tteterozygous  Line.--Data  on the  growth  of  the  heterozygous line are 1168  GALACTOSEM~IC  CELLS  IN  CULTURE 
given in Table IV. For some time marked technical problems were encountered 
with the handling of this line, and the absolute growth in most of the experi- 
ments has been intractably  slow.  Only two  point  experiments have  thus  far 
been done.  However, all were terminated  before the  cell density reached the 
usual plateau levels. It is clear from Table IV that  the heterozygous line was 
more variable than the homozygous ones in its relative growth in glucose and 
TABLE V 
Isotope Experiments 
Line 
(AA) MI4 
(aa)  JDU'  i 
(AA)  Be' 
(AA) RCU,  i 
AA (AA)  BEn 
(AA)  BEsO  [ 
(AA)  SE5  i  b 
(aa) By5 
aa  (aa) JDU" 
(aa) JDU  9  i 
(aa) JDU  17 
(Aa)  MAD  4 
Aa  (Aa) MAD (~) 
?'Age" 
i 
i 
J 
days 
27 
27 
65 
79 
72 
160 
71 
56 
55 
119 
192 
68 
76 
Tissue of 
M-No.  origin 
16  Marrow 
10  " 
8  X  10~  Skin 
32  " 
2  X  105  " 
3.8  X  10i2  " 
9.6  X  10  5  " 
10  Skin 
240  " 
9.6  X  104  " 
2.3  X  I0  l°  " 
40  Skin 
128  " 
Millions of cells 
counted 
7.8 
3.9 
4.3 
7.7 
8.3 
1 Blake bottle 
6.3 
5.3 
1 Blake bottle 
1  " 
1.5 
2.8 
(1) 
C  ~40~ from 
0  4 gal: counts 
per 105 cells 
per minute 
220 
0 
352 
87 
157 
1235 
266 
67 
66 
(2) 
Cl*O2 from 
Ct4glu  counts 
per 105 cells 
per minute 
380 
870 
807 
298 
529 
3544 
944 
590 
2644 
4541 
720 
735 
Ratio 
(1): (2) 
0.6 
0 
0.4 
0.3 
0.3 
0.3 
0.3 
(0) 
0.01 
0 
0 
0.09 
0.09 
AA  denotes non-galactosemic patients, A a the presumably heterozygous mother of galactosemic patient JDU, and aa 
denotes galaetosemic patients. The superscript on the letters designating the line is 1, plus the number of subcultures. 
Ago is the time between the date of biopsy and the date of the experiment. Each unique combination of letters represents 
a different patient. Each flask contained of the order of 105 cells, and 0.472 Fc. of either galactose-/-C  14 or glucose4-C  1. 
(approximately 250,000 c.P.~.). 
* Counts entered here are c.P.M,  per  1/3.2  of a  Blake bottle. 
galactose. However, in three experiments, all terminated before plateau levels, 
growth in  glucose and  galactose were so close that  a  true  difference appears 
unlikely.  However,  there  must  be factors influencing  the  growth  of this  cell 
line over which we still exercise imperfect control. 
Isotope Experiments.--The  results  of  the  isotope  experiments  are  given in 
Table V. Note that the ratio of counts as C1402, from galactose to counts from 
glucose appears to be fairly constant and to reflect genotype. The  effect seems 
to persist over many months, and after the cells have increased many billion- 
fold. The variation within genotype of counts per million cells is probably due 
largely to our crude method of enumerating cells,  which  is accurate to but  a 
factor of 2. R.  S.  KROOTH AND A.  N.  WEINBERG  1169 
GENERAL REMARKS 
In addition  to galactosemia, a  number of other  diseases are probably sus- 
ceptible to study in this way, e.g.,  orotic aciduria (Huguley et al.,  1959,  Smith 
and  Huguley,  1960),  acatalasemia  (Takahara  1952,  Takahara  et  al.,  1960, 
Wyngaarden,  1960),  cystathioninuria  (Harris et  al.,  1959)  and perhaps some 
of the other hexose and pentosurias (see Stanbury et al.,  1960,  Rapaport, 1959, 
and Hsia, 1959).  Indeed the number of possible diseases appears to be increas- 
ing sharply with time. 
Cells of this kind are, as noted earlier, of potential use in the demonstration 
of  genetic  exchange.  The  possibility  of  transforming  human  cells  has  been 
made particularly attractive by Gartler's (1960)  recent work suggesting  that 
Earle's "L" cells will incorporate polymerized DNA as such from the medium 
into  their  nuclei.  "Primary" human  cells offer certain  advantages.  They are 
at present the sole source of mutant mammalian cells,  where both the genetics 
and the identity of the abnormal protein  (a particular enzyme in the present 
case) are known. 
SUMMARY 
Cell lines were developed from biopsies on galactosemic and non-galactosemic 
patients.  It was shown that one can discriminate between lines from the two 
types of donors by their relative growth in glucose and galactose and by their 
ability  to  oxidize  galactose-l-C  1..  The  latter  method  was  successful  in  dis- 
tinguishing a heterozygous cell line from the normal ones. Sensitivity of galac- 
tosemic  cells  to  galactose  was  suggested  by  some  of  the  experiments.  The 
kinetics of growth were in some ways reminiscent of a  similar phenomenon in 
the  transferase mutants of E.  coli,  though  in  the  human  cells the effect was 
much less marked. 
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and encouragement. The two patients JDU and MAD were referred to us through Dr.  Julius 
Metrakos, to whom we are most grateful. Dr. Helen Brickman, who has followed the family 
for some time, was most generous in her interest, and encouraged the patients to come to the 
National Institutes. We are also deeply indebted to Dr. Ntinos Myrianthopoulos for assistance 
in locating this family. Dr. Stanton S. Segal kindly permitted us to perform the biopsy on the 
patient  BY. Finally, we should like to acknowledge with gratitude the  technical assistance 
of Miss Mary Jane Madden. 
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EXPLANATION  OF PLATES 
PLATE 112 
FIG. 1.  Exfoliation from biopsy. SK line. X  150. THE JOURNAL OF EXPERIMENTAL MEDICINE  VOL.  113  PLATE  112 
(Krooth  and  Weinberg:  Galactosemic  cells  in  culture) PLATE 113 
FIG. 2:  Growth in 100 mg.  per  cent glucose  or  galactose.  Growth  in galactose 
is shown in the two left hand panels and growth in glucose in the  right hand ones. 
AA  refers  to the normal BE line and aa to the galactosemic JDU line. ;< 75. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL. 113  PLATE  113 
FIG.  2 
(Krooth  and  Weinberg:  Galactosemic  cells  in  culture) 